Literature DB >> 17538893

Francisella tularensis has a significant extracellular phase in infected mice.

Colin A Forestal1, Meenakshi Malik, Sally V Catlett, Anne G Savitt, Jorge L Benach, Timothy J Sellati, Martha B Furie.   

Abstract

The ability of Francisella tularensis to replicate in macrophages has led many investigators to assume that it resides primarily intracellularly in the blood of mammalian hosts. We have found this supposition to be untrue. In almost all cases, the majority of F. tularensis recovered from the blood of infected mice was in plasma rather than leukocytes. This distribution was observed irrespective of size of inoculum, route of inoculation, time after inoculation, or virulence of the infecting strain. Our findings yield new insight into the pathogenesis of tularemia and may have important ramifications in the search for anti-Francisella therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17538893     DOI: 10.1086/518611

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  74 in total

1.  Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis.

Authors:  Ravinder Kaur; Shan Chen; Maria T Arévalo; Qingfu Xu; Yanping Chen; Mingtao Zeng
Journal:  Clin Vaccine Immunol       Date:  2012-01-25

2.  Detrimental Influence of Alveolar Macrophages on Protective Humoral Immunity during Francisella tularensis SchuS4 Pulmonary Infection.

Authors:  Donald J Steiner; Yoichi Furuya; Dennis W Metzger
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

3.  Antibodies contribute to effective vaccination against respiratory infection by type A Francisella tularensis strains.

Authors:  Gopi Mara-Koosham; Julie A Hutt; C Rick Lyons; Terry H Wu
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

4.  The presence of infectious extracellular Francisella tularensis subsp. novicida in murine plasma after pulmonary challenge.

Authors:  J-J Yu; E K Raulie; A K Murthy; M N Guentzel; K E Klose; B P Arulanandam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12-18       Impact factor: 3.267

5.  Directed screen of Francisella novicida virulence determinants using Drosophila melanogaster.

Authors:  Monika K Ahlund; Patrik Rydén; Anders Sjöstedt; Svenja Stöven
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

6.  Francisella tularensis: a red-blooded pathogen.

Authors:  J Wayne Conlan
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

7.  Mice Housed at Elevated Vivarium Temperatures Display Enhanced T-cell Response and Survival to Francisella tularensis.

Authors:  Robert L Rubin
Journal:  Comp Med       Date:  2017-12-01       Impact factor: 0.982

8.  Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.

Authors:  Heather J Ray; Yu Cong; Ashlesh K Murthy; Dale M Selby; Karl E Klose; Jeffrey R Barker; M Neal Guentzel; Bernard P Arulanandam
Journal:  Clin Vaccine Immunol       Date:  2009-02-11

9.  Environmental and intracellular regulation of Francisella tularensis ripA.

Authors:  James R Fuller; Todd M Kijek; Sharon Taft-Benz; Thomas H Kawula
Journal:  BMC Microbiol       Date:  2009-10-12       Impact factor: 3.605

10.  Comparative antimicrobial activity of granulysin against bacterial biothreat agents.

Authors:  Janice J Endsley; Alfredo G Torres; Christine M Gonzales; Valeri G Kosykh; Vladimir L Motin; Johnny W Peterson; D Mark Estes; Gary R Klimpel
Journal:  Open Microbiol J       Date:  2009-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.